Stonebridge Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $13.1M | Buy |
26,102
+697
| +3% | +$335K | 0.84% | 41 |
|
|
2026
Q1 | $12.5M | Sell |
25,405
-114
| -0.4% | -$61.9K | 0.87% | 41 |
|
|
2025
Q4 | $14.8M | Sell |
25,519
-140
| -0.5% | -$79.2K | 1.02% | 34 |
|
|
2025
Q3 | $12.4M | Buy |
25,659
+130
| +0.5% | +$60.5K | 0.89% | 39 |
|
|
2025
Q2 | $10.4M | Buy |
25,529
+82
| +0.3% | +$34.3K | 0.79% | 44 |
|
|
2025
Q1 | $12.7M | Buy |
25,447
+786
| +3% | +$426K | 1.03% | 36 |
|
|
2024
Q4 | $12.8M | Buy |
24,661
+499
| +2% | +$274K | 1.03% | 34 |
|
|
2024
Q3 | $14.9M | Sell |
24,162
-695
| -3% | -$411K | 1.22% | 26 |
|
|
2024
Q2 | $13.7M | Sell |
24,857
-7
| -0% | -$4.01K | 1.21% | 27 |
|
|
2024
Q1 | $14.5M | Buy |
24,864
+198
| +0.8% | +$111K | 1.3% | 26 |
|
|
2023
Q4 | $13.1M | Buy |
24,666
+710
| +3% | +$344K | 1.31% | 23 |
|
|
2023
Q3 | $12.1M | Buy |
23,956
+533
| +2% | +$284K | 1.33% | 22 |
|
|
2023
Q2 | $12.2M | Buy |
23,423
+170
| +0.7% | +$91.7K | 1.3% | 23 |
|
|
2023
Q1 | $13.4M | Buy |
23,253
+381
| +2% | +$215K | 1.53% | 14 |
|
|
2022
Q4 | $12.6M | Buy |
22,872
+566
| +3% | +$300K | 1.49% | 18 |
|
|
2022
Q3 | $11.3M | Buy |
22,306
+461
| +2% | +$258K | 1.46% | 17 |
|
|
2022
Q2 | $11.9M | Buy |
21,845
+496
| +2% | +$273K | 1.44% | 16 |
|
|
2022
Q1 | $12.6M | Buy |
21,349
+815
| +4% | +$468K | 1.36% | 20 |
|
|
2021
Q4 | $13.7M | Buy |
20,534
+428
| +2% | +$267K | 1.51% | 15 |
|
|
2021
Q3 | $11.5M | Sell |
20,106
-305
| -1% | -$167K | 1.4% | 17 |
|
|
2021
Q2 | $10.3M | Buy |
20,411
+1,319
| +7% | +$622K | 1.25% | 26 |
|
|
2021
Q1 | $8.71M | Buy |
19,092
+1,877
| +11% | +$896K | 1.15% | 32 |
|
|
2020
Q4 | $8.02M | Buy |
17,215
+62
| +0.4% | +$29.1K | 1.21% | 28 |
|
|
2020
Q3 | $7.57M | Sell |
17,153
-336
| -2% | -$139K | 1.36% | 25 |
|
|
2020
Q2 | $6.34M | Sell |
17,489
-794
| -4% | -$266K | 1.17% | 34 |
|
|
2020
Q1 | $5.18M | Sell |
18,283
-470
| -3% | -$148K | 1.09% | 34 |
|
|
2019
Q4 | $6.09M | Sell |
18,753
-78
| -0.4% | -$23.7K | 0.99% | 40 |
|
|
2019
Q3 | $5.49M | Sell |
18,831
-11,785
| -38% | -$3.37M | 0.95% | 46 |
|
|
2019
Q2 | $8.99M | Sell |
30,616
-2,650
| -8% | -$730K | 1.6% | 12 |
|
|
2019
Q1 | $9.11M | Sell |
33,266
-143
| -0.4% | -$35.6K | 1.69% | 9 |
|
|
2018
Q4 | $7.48M | Sell |
33,409
-1,616
| -5% | -$379K | 1.74% | 14 |
|
|
2018
Q3 | $8.55M | Sell |
35,025
-735
| -2% | -$169K | 1.72% | 12 |
|
|
2018
Q2 | $7.41M | Buy |
35,760
+339
| +1% | +$72K | 1.61% | 17 |
|
|
2018
Q1 | $7.31M | Sell |
35,421
-1,135
| -3% | -$238K | 1.68% | 13 |
|
|
2017
Q4 | $6.94M | Sell |
36,556
-595
| -2% | -$114K | 1.59% | 17 |
|
|
2017
Q3 | $7.03M | Sell |
37,151
-472
| -1% | -$85.5K | 1.73% | 12 |
|
|
2017
Q2 | $6.56M | Sell |
37,623
-346
| -0.9% | -$58.1K | 1.72% | 15 |
|
|
2017
Q1 | $5.83M | Buy |
37,969
+1,338
| +4% | +$205K | 1.59% | 17 |
|
|
2016
Q4 | $5.17M | Sell |
36,631
-1,115
| -3% | -$164K | 1.53% | 16 |
|
|
2016
Q3 | $6M | Buy |
37,746
+920
| +2% | +$142K | 1.88% | 9 |
|
|
2016
Q2 | $5.44M | Sell |
36,826
-4,837
| -12% | -$714K | 1.85% | 14 |
|
|
2016
Q1 | $5.9M | Sell |
41,663
-1,021
| -2% | -$137K | 2.08% | 10 |
|
|
2015
Q4 | $6.05M | Buy |
42,684
+1,091
| +3% | +$146K | 2.21% | 9 |
|
|
2015
Q3 | $5.09M | Buy |
41,593
+1,505
| +4% | +$196K | 2.05% | 10 |
|
|
2015
Q2 | $5.2M | Buy |
40,088
+1,390
| +4% | +$181K | 2% | 9 |
|
|
2015
Q1 | $5.2M | Buy |
38,698
+1,826
| +5% | +$235K | 2.01% | 7 |
|
|
2014
Q4 | $4.62M | Buy |
36,872
+2,470
| +7% | +$300K | 1.9% | 9 |
|
|
2014
Q3 | $4.19M | Buy |
34,402
+1,245
| +4% | +$151K | 1.85% | 9 |
|
|
2014
Q2 | $3.91M | Buy |
33,157
+745
| +2% | +$87.7K | 1.76% | 11 |
|
|
2014
Q1 | $3.9M | Buy |
32,412
+186
| +0.6% | +$22.1K | 1.91% | 8 |
|
|
2013
Q4 | $3.59M | Buy |
+32,226
| New | +$3.2M | 1.85% | 10 |
|
Other funds holding TMO
Stonebridge Capital Advisors's TMO Position: Q2 2026 in Review
Stonebridge Capital Advisors increased its Thermo Fisher Scientific (TMO) stake by 2.7% in Q2 2026, buying an estimated $335K and bringing the position to 26,102 shares worth $13.1M. The position accounts for 0.84% of the portfolio, ranked #41.
Stonebridge Capital Advisors first reported a position in TMO in Q4 2013 and has held it in 51 quarters since. The position peaked at $14.9M in Q3 2024. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Stonebridge Capital Advisors held 26,102 shares of Thermo Fisher Scientific worth $13.1M as of Q2 2026.
- Stonebridge Capital Advisors bought 697 Thermo Fisher Scientific shares in Q2 2026, an estimated $335K.
- Thermo Fisher Scientific made up 0.84% of Stonebridge Capital Advisors's portfolio in Q2 2026, its #41 holding.
- Stonebridge Capital Advisors first reported a position in Thermo Fisher Scientific in Q4 2013 and has held it in 51 quarters since.
- Stonebridge Capital Advisors's Thermo Fisher Scientific position peaked at $14.9M in Q3 2024.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Stonebridge Capital Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.